SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Nasser Ebrahimi Daryani, Maryam Sadr, Shirin Moossavi, Sepideh Shahkarami, Samaneh Soltani, Elham Farhadi, Nima Rezaei, Significance of IL-1RA Polymorphism in Iranian Patients with Inflammatory Bowel Disease, Digestive Diseases and Sciences, 2015, 60, 5, 1389

    CrossRef

  2. 2
    S. T. Bozdoğan, B. Erol, A. Dursun, G. Bozdoğan, I. Dönmez, N. A. Mungan, G. Seydaoglu, The IL-1RN and IL-4 gene polymorphisms are potential genetic markers of susceptibility to bladder cancer: a case–control study, World Journal of Urology, 2015, 33, 3, 389

    CrossRef

  3. 3
    Daniela S. Ardelean, Melissa Yin, Mirjana Jerkic, Madonna Peter, Bo Ngan, Robert S. Kerbel, F. Stuart Foster, Michelle Letarte, Anti-VEGF therapy reduces intestinal inflammation in Endoglin heterozygous mice subjected to experimental colitis, Angiogenesis, 2014, 17, 3, 641

    CrossRef

  4. 4
    Nahid Fakhraei, Amir Hossein Abdolghaffari, Bahram Delfan, Ata Abbasi, Nastaran Rahimi, Azadeh Khansari, Reza Rahimian, Ahmad Reza Dehpour, Protective Effect of Hydroalcoholic Olive Leaf Extract on Experimental Model of Colitis in Rat: Involvement of Nitrergic and Opioidergic Systems, Phytotherapy Research, 2014, 28, 9
  5. 5
    Mairi H. McLean, Markus F. Neurath, Scott K. Durum, Targeting Interleukins for the Treatment of Inflammatory Bowel Disease—What Lies Beyond Anti-TNF Therapy?, Inflammatory Bowel Diseases, 2014, 20, 2, 389

    CrossRef

  6. 6
    Mònica Aguilera, Trevor Darby, Silvia Melgar, The complex role of inflammasomes in the pathogenesis of Inflammatory Bowel Diseases – Lessons learned from experimental models, Cytokine & Growth Factor Reviews, 2014, 25, 6, 715

    CrossRef

  7. 7
    Isabella Rauch, Eva Hainzl, Felix Rosebrock, Susanne Heider, Clarissa Schwab, David Berry, Dagmar Stoiber, Michael Wagner, Christa Schleper, Alexander Loy, Tim Urich, Mathias Müller, Birgit Strobl, Lukas Kenner, Thomas Decker, Type I interferons have opposing effects during the emergence and recovery phases of colitis, European Journal of Immunology, 2014, 44, 9
  8. 8
    Limei Li, Zhenzhe Liu, Xinyu Yang, Huimin Yan, Shisan Bao, Jian Fei, Bioluminescence imaging for IL-1β expression in experimental colitis, Journal of Inflammation, 2013, 10, 1, 16

    CrossRef

  9. 9
    Periklis Vounotrypidis, Georgios Kouklakis, Konstantinos Anagnostopoulos, Petros Zezos, Alexandros Polychronidis, Efstratios Maltezos, Eleni Efremidou, Michael Pitiakoudis, Nikolaos Lyratzopoulos, Interleukin-1 associations in inflammatory bowel disease and the enteropathic seronegative spondylarthritis, Autoimmunity Highlights, 2013, 4, 3, 87

    CrossRef

  10. 10
    M. Coccia, O. J. Harrison, C. Schiering, M. J. Asquith, B. Becher, F. Powrie, K. J. Maloy, IL-1  mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4+ Th17 cells, Journal of Experimental Medicine, 2012, 209, 9, 1595

    CrossRef

  11. 11
    Nicoline M. Korthagen, Coline H. M. van Moorsel, Karin M. Kazemier, Henk J. T. Ruven, Jan C. Grutters, IL1RN genetic variations and risk of IPF: a meta-analysis and mRNA expression study, Immunogenetics, 2012, 64, 5, 371

    CrossRef

  12. 12
    Tomasz Banasiewicz, Jarosław Walkowiak, Slawomira Drzymała-Czyż, Maciej Borejsza-Wysocki, Przemysław Majewski, Maciej Biczysko, Zoran Stojcev, Karl-Heinz Herzig, Michał Drews, Stricture of ileo-anal J pouch anastomosis increased the intensity of pouchitis in an experimental rat model, Medical Science Monitor, 2012, 18, 10, BR409

    CrossRef

  13. You have free access to this content13
    N. P. Barlo, C. H. M. van Moorsel, N. M. Korthagen, M. Heron, G. T. Rijkers, H. J. T. Ruven, J. M. M. van den Bosch, J. C. Grutters, Genetic variability in the IL1RN gene and the balance between interleukin (IL)-1 receptor agonist and IL-1β in idiopathic pulmonary fibrosis, Clinical & Experimental Immunology, 2011, 166, 3
  14. 14
    Vito D. Corleto, Cristiano Pagnini, Giovanna Margagnoni, Danila Guagnozzi, Maria Simona Torre, Michela Martorelli, Anna Latiano, Vito Annese, Renzo Caprilli, Gianfranco Delle Fave, IL-1β-511 and IL-1RN*2 polymorphisms in inflammatory bowel disease: An Italian population study and meta-analysis of European studies, Digestive and Liver Disease, 2010, 42, 3, 179

    CrossRef

  15. 15
    Azadeh Hosseini-Tabatabaei, Hadi Esmaily, Reza Rahimian, Reza Khorasani, Maryam Baeeri, Ahmadreza Barazesh-Morgani, Fatemeh Sari-Aslani, Mohammad Abdollahi, Benefit of nicorandil using an immunologic murine model of experimental colitis, Open Life Sciences, 2009, 4, 1

    CrossRef

  16. 16
    Elizabeth Sapey, Ali Ahmad, Darren Bayley, Paul Newbold, Noel Snell, Paul Rugman, Robert A. Stockley, Imbalances Between Interleukin-1 and Tumor Necrosis Factor Agonists and Antagonists in Stable COPD, Journal of Clinical Immunology, 2009, 29, 4, 508

    CrossRef

  17. 17
    Mathias Jung, Sven Triebel, Timm Anke, Elke Richling, Gerhard Erkel, Influence of apple polyphenols on inflammatory gene expression, Molecular Nutrition & Food Research, 2009, 53, 10
  18. 18
    Louis Kuoping Chao, Kuo-Feng Hua, Hsien-Yeh Hsu, Sen-Sung Cheng, I-Fan Lin, Chia-Jung Chen, Shui-Tein Chen, Shang-Tzen Chang, Cinnamaldehyde inhibits pro-inflammatory cytokines secretion from monocytes/macrophages through suppression of intracellular signaling, Food and Chemical Toxicology, 2008, 46, 1, 220

    CrossRef

  19. 19
    H A Schulze, R Häsler, N Mah, T Lu, S Nikolaus, C M Costello, S Schreiber, From model cell line to in vivo gene expression: disease-related intestinal gene expression in IBD, Genes and Immunity, 2008, 9, 3, 240

    CrossRef

  20. 20
    Ki Han Kwon, Hajime Ohigashi, Akira Murakami, Dextran sulfate sodium enhances interleukin-1β release via activation of p38 MAPK and ERK1/2 pathways in murine peritoneal macrophages, Life Sciences, 2007, 81, 5, 362

    CrossRef

  21. 21
    Mate Stulic, Farah D. Lubin, Phyllis M. O’Donnell, Steven P. Tammariello, Dennis W. McGee, Effect of the α3β1 integrin on the IL-1 stimulated activation of c-Jun N-terminal kinase (JNK) in CACO-2 cells, Cytokine, 2007, 37, 2, 163

    CrossRef

  22. 22
    Jillian Grygas, Nicole Steiger, Carrie L. LeSeur, Benjamin L. Unger, Dennis W. McGee, Hepatocyte growth factor enhances IL-1β stimulated IL-8 secretion by Caco-2 epithelial cells, In Vitro Cellular & Developmental Biology - Animal, 2007, 43, 3-4, 147

    CrossRef

  23. 23
    C. Schmidt, T. Giese, R. Goebel, M. Schilling, T. Marth, A. Ruether, S. Schreiber, S. Zeuzem, S. C. Meuer, A. Stallmach, Interleukin-18 is increased only in a minority of patients with active Crohn’s disease, International Journal of Colorectal Disease, 2007, 22, 9, 1013

    CrossRef

  24. 24
    I Ballester, A Daddaoua, R López-Posadas, A Nieto, M D Suárez, A Zarzuelo, O Martínez-Augustin, F Sánchez Medina, The bisphosphonate alendronate improves the damage associated with trinitrobenzenesulfonic acid-induced colitis in rats, British Journal of Pharmacology, 2007, 151, 2
  25. 25
    Monica Froicu, Yan Zhu, Margherita T. Cantorna, Vitamin D receptor is required to control gastrointestinal immunity in IL-10 knockout mice, Immunology, 2006, 117, 3
  26. 26
    Shinya Ashizuka, Naoto Ishikawa, Johji Kato, Junichi Yamaga, Haruhiko Inatsu, Tanenao Eto, Kazuo Kitamura, Effect of adrenomedullin administration on acetic acid-induced colitis in rats, Peptides, 2005, 26, 12, 2610

    CrossRef

  27. 27
    Ki Han Kwon, Akira Murakami, Ryohei Hayashi, Hajime Ohigashi, Interleukin-1β targets interleukin-6 in progressing dextran sulfate sodium-induced experimental colitis, Biochemical and Biophysical Research Communications, 2005, 337, 2, 647

    CrossRef

  28. 28
    Cesare Hassan, Angelo Zullo, Salvatore MA Campo, Sergio Morini, New insights into the biological therapy of Crohn’s disease, Expert Opinion on Therapeutic Patents, 2005, 15, 4, 409

    CrossRef

  29. 29
    Robert M Penner, Karen L Madsen, Richard N Fedorak, Postoperative Crohn's disease, Inflammatory Bowel Diseases, 2005, 11, 8